Virat Crane Industries Limited (BOM:519457)

Verve Therapeutics Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul 25, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Market Capitalization	947	1,041	999	593	621	436
Market Cap Growth	4.21%	4.21%	68.45%	-4.51%	42.39%	53.60%
Enterprise Value	1,017	1,041	1,051	621	603	378
Last Close Price	46.39	50.96	48.90	29.03	30.40	21.35
PE Ratio	20.35	22.31	9.87	-	10.39	7.19
PS Ratio	0.68	0.75	0.74	0.48	0.64	0.51
PB Ratio	1.38	1.51	1.56	1.10	1.07	0.84
P/TBV Ratio	1.61	1.77	1.85	1.35	1.29	1.04
P/FCF Ratio	-	-	71.97	-	-	8.33
P/OCF Ratio	51.25	56.30	15.47	7.78	14.36	6.12
EV/Sales Ratio	0.73	0.75	0.78	0.51	0.63	0.45
EV/EBITDA Ratio	13.62	13.93	8.53	6.78	6.98	4.29
EV/EBIT Ratio	15.11	15.45	8.78	7.02	7.25	4.46
EV/FCF Ratio	-54.93	-	75.71	-	-	7.23
Debt / Equity Ratio	0.11	0.11	0.09	0.12	0.06	0.07
Debt / EBITDA Ratio	1.04	1.04	0.45	0.72	0.39	0.39
Debt / FCF Ratio	-	-	4.03	-	-	0.66
Asset Turnover	1.61	1.61	1.70	1.70	1.44	1.40
Inventory Turnover	12.80	12.80	7.78	5.71	5.40	4.62
Quick Ratio	0.85	0.85	0.97	0.49	0.84	0.85
Current Ratio	2.51	2.51	2.51	1.61	2.08	2.15
Return on Equity (ROE)	7.03%	7.03%	17.15%	-7.28%	10.85%	12.37%
Return on Assets (ROA)	4.86%	4.86%	9.44%	7.61%	7.75%	8.71%
Return on Capital (ROIC)	5.76%	5.76%	11.49%	9.07%	8.90%	10.16%
Return on Capital Employed (ROCE)	9.40%	9.40%	17.90%	15.80%	14.30%	16.20%
Earnings Yield	4.92%	4.48%	10.14%	-6.88%	9.62%	13.91%
FCF Yield	-1.95%	-1.78%	1.39%	-5.66%	-3.12%	12.01%
Buyback Yield / Dilution	-0.19%	-0.19%	-	-	-	-
Total Shareholder Return	-	-0.19%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.